Trending
- First-in-Human: Jyoti Malhotra, MD, MPH on Phase I Trials, Lung Cancer in 2026, and Yale
- Fractionated SRS Should Be Standard of Care After Brain Metastasis Surgery
- Transcriptional intermediary factor 1 gamma-based multitarget gene therapeutic strategy for triple-negative breast cancer
- Hypofractionated PMRT Shows Durable 10-Year Control in High-Risk Breast Cancer
- Exploring Advancements in Targeting KRAS in Cholangiocarcinoma
- Fractionated SRS Tops Single-Fraction SRS After Brain Metastasis Resection
- Sequencing CAR T Therapy and Bispecifics in Follicular and Mantle Cell Lymphoma
- Cell atlas of the developing human meninges reveals a dura-like nature of meningiomas
